Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hylenex SC vs IV Rehydration in Pediatric Dehydration
NCT00773175Phase 4Completed
- Sponsor
- Halozyme Therapeutics, Inc.
- Start
- Oct 2008
- Primary completion
- Nov 2009
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of hyaluronidase in dehydration (2 arms), sponsored by Halozyme Therapeutics, Inc. Primary endpoint: Mean Total Volume of Fluid Administered at a Single Infusion Site. Started Oct 2008; status: completed.
02
Drugs
hyaluronidase
03
Conditions
dehydration
Beyond the preview
Go deeper on NCT00773175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00773175.